ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)Željko Reiner, Alberico L. Catapano, Guy De Backer et al.|European Heart Journal|2011Cited by 3.5k
Detection of Significant Coronary Artery Disease by Noninvasive Anatomical and Functional ImagingDanilo Neglia, Philipp A. Kaufmann, Dominique Le Guludec et al.|Circulation Cardiovascular Imaging|2015Cited by 412
Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemiaRoberto Ferrari, Alberico L. Catapano, Carlos Aguíar et al.|European Heart Journal Supplements|2016Cited by 101
A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate–statin combination therapyCarlos Aguíar, Roberto Ferrari, Eduardo Alegría et al.|Atherosclerosis Supplements|2015Cited by 84
Imaging in Patients with Suspected Acute Heart Failure: Timeline Approach Position Statement on Behalf of the Heart Failure Association of the European Society of CardiologyJelena Čelutkienė, Petar Seferović, Mitja Lainščak et al.|European Journal of Heart Failure|2019Cited by 69